| Literature DB >> 9890046 |
Abstract
With the adoption of the new authorization system, all regulatory needs for veterinary medicinal products have been fulfilled with the European Union. This system, indeed, provides access to a continent-wide market to innovative products, in particular vaccines, and facilitates access to the markets of the Member States for other products. This should have a clearly favorable impact on the veterinary vaccines industry.Mesh:
Substances:
Year: 1999 PMID: 9890046 DOI: 10.1016/s0065-3519(99)80045-7
Source DB: PubMed Journal: Adv Vet Med ISSN: 1093-975X